The Frailty Crisis: Why NHS England Is Failing Our Aging Population

A recent report from the Public Accounts Committee (PAC) has exposed a staggering failure in the primary care system, revealing that general practitioners assessed only 17% of patients aged 65 and over for frailty during the 2024–2025 period. Despite contractual obligations to provide comprehensive support for those living with moderate or severe frailty, the data suggests that millions of vulnerable older adults are being left without the preventive care they desperately need.

What Is Frailty and Why Does It Matter?

In a clinical context, frailty is not merely a sign of aging; it is a distinct, progressive medical syndrome characterized by a decline in physiological resilience. Patients living with frailty are significantly more susceptible to adverse health outcomes, including:

• Increased risk of falls and fractures
• Cognitive decline and delirium
• Incontinence
• Adverse reactions to polypharmacy (the use of multiple medications)

The clinical stakes are high. Older adults diagnosed with severe frailty face a nearly six-fold increase in the risk of emergency hospital admission and are five times more likely to die within a single year compared to their more robust peers.

The £6 Billion Price Tag of Inaction

The human cost of this care deficit is mirrored by a massive financial burden. According to a National Audit Office (NAO) estimate, inadequate frailty support costs the NHS approximately £5.8 billion annually. Much of this expenditure is driven by crisis-level care—such as A&E admissions following a fall—that could have been mitigated through proactive, early-stage intervention.

When frailty is identified early, clinicians can implement personalized care plans, review medication regimens and perform falls-risk assessments. These interventions are proven to gradual the rate of decline and help patients maintain their independence for as long as possible.

A System Under Strain: Digital Access vs. Clinical Care

The PAC report highlights a troubling tension within NHS England (NHSE) strategy. While NHSE has aggressively prioritized improving digital access to general practice, this transition appears to have come at the expense of essential face-to-face clinical work. NHSE has acknowledged that the focus on digital transformation may have inadvertently displaced critical frailty assessments.

there is a clear “postcode lottery” of care. While some regions managed to assess over 90% of their registered older population, 32 local NHS areas failed to assess even 10% of patients in the same demographic. This disparity suggests that the issue is not just a lack of resources, but a failure of systemic prioritization, and accountability.

Key Takeaways

• Low Assessment Rates: Only 17% of eligible older patients received a frailty assessment in 2024–2025.
• Missed Opportunities: Less than 20% of those with severe frailty received required medication reviews or falls-risk assessments.
• Financial Impact: Inadequate support contributes to a £5.8 billion annual cost to the NHS.
• Accountability Gap: A lack of clarity between Integrated Care Boards (ICBs) and GP practices has left a vacuum in responsibility.

The Path Forward: Can Pharmacy Teams Bridge the Gap?

There is growing consensus that the burden of frailty management cannot rest on GPs alone. Community pharmacists have expressed a strong desire to take on more clinical responsibilities, such as conducting medication reviews, which are vital for preventing adverse drug events in frail patients.

Henry Gregg, chief executive of the National Pharmacy Association, emphasized that pharmacies are uniquely positioned to provide this care. “Pharmacies are conveniently located on people’s doorsteps and know their patients well,” Gregg stated. “With the right levels of funding support and buy-in from the rest of the NHS, they can help those who need it the most.”

Conclusion

The findings from the Public Accounts Committee serve as a wake-up call for the healthcare system. As the UK population continues to age, the current approach to frailty is unsustainable. To protect the health and dignity of older adults, NHS England must move beyond administrative targets and ensure that local systems are properly funded and held accountable for delivering the preventive care that patients are contractually and ethically entitled to receive.

Frequently Asked Questions (FAQ)

What is a frailty assessment?
A frailty assessment is a clinical evaluation used to identify how much “reserve” a patient has. It typically involves checking mobility, cognitive function, and medication use to determine the level of support required to prevent further decline.

Why is medication review vital for frail patients?
As patients age, their bodies process drugs differently. A medication review ensures that patients are not taking unnecessary or potentially harmful combinations of drugs that could lead to dizziness, confusion, or falls.

Who is responsible for my frailty care?
While your GP is the primary point of contact, the responsibility for commissioning and overseeing these services lies with your local Integrated Care Board (ICB). The recent report stresses that this division of responsibility must be clarified to ensure no patient falls through the cracks.